Chemours
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,615,000 | $1,368,000 | $1,394,000 | $1,501,000 |
Gross Profit | 278,000 | 236,000 | 273,000 | 286,000 |
EBITDA | -187,000 | 154,000 | 153,000 | 117,000 |
EBIT | -278,000 | 66,000 | 75,000 | 39,000 |
Net Income | -381,000 | -4,000 | -8,000 | -27,000 |
Net Change In Cash | 1,615,000 | 1,368,000 | 1,394,000 | 1,501,000 |
Free Cash Flow | 69,000 | -196,000 | 29,000 | 63,000 |
Cash | 502,000 | 464,000 | 713,000 | 596,000 |
Basic Shares | 150,238 | 150,410 | 149,826 | 149,698 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $5,782,000 | $6,027,000 | $6,794,000 | $6,345,000 |
Gross Profit | 1,151,000 | 1,306,000 | 1,616,000 | 1,381,000 |
EBITDA | 692,000 | 197,000 | 1,204,000 | 1,205,000 |
EBIT | 391,000 | -110,000 | 913,000 | 888,000 |
Net Income | 86,000 | -238,000 | 578,000 | 608,000 |
Net Change In Cash | 5,782,000 | 6,027,000 | 6,794,000 | 6,345,000 |
Cost of Revenue | -215,000 | 480,000 | ||
Free Cash Flow | -993,000 | 186,000 | 447,000 | 543,000 |
Cash | 713,000 | 1,203,000 | 1,102,000 | 1,451,000 |
Basic Shares | 150,014 | 148,912 | 158,303 | 168,698 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.58 |
2025-03-31 | $0.13 |
2024-12-31 | $0.11 |
